Compare LH & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LH | CNC |
|---|---|---|
| Founded | 1971 | 1984 |
| Country | United States | United States |
| Employees | 70000 | N/A |
| Industry | Medical Specialities | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.7B | 21.5B |
| IPO Year | 2005 | 2001 |
| Metric | LH | CNC |
|---|---|---|
| Price | $255.68 | $58.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 16 |
| Target Price | ★ $311.33 | $46.75 |
| AVG Volume (30 Days) | 705.0K | ★ 6.2M |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | ★ 1.12% | N/A |
| EPS Growth | ★ 18.33 | N/A |
| EPS | ★ 3.35 | 3.11 |
| Revenue | $13,951,700,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $8.26 | $8.31 |
| Revenue Next Year | $4.81 | $1.05 |
| P/E Ratio | $75.04 | ★ $18.68 |
| Revenue Growth | 7.25 | ★ 19.44 |
| 52 Week Low | $239.75 | $25.08 |
| 52 Week High | $293.72 | $62.21 |
| Indicator | LH | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 44.16 | 79.93 |
| Support Level | $247.44 | $33.00 |
| Resistance Level | $275.06 | N/A |
| Average True Range (ATR) | 6.31 | 1.98 |
| MACD | -0.03 | 0.22 |
| Stochastic Oscillator | 42.25 | 83.83 |
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.